Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin added to chloroquine for hospitalized adults with COVID-19
NL-OMON49080Phase 3Suspended
- Sponsor
- Erasmus MC
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing Chloroquine alone with Chloroquine + azithromycin (2 arms). Primary endpoint: Clinical cure at day 7. Started Apr 2020; status: suspended.
02
Drugs
azithromycinchloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON49080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49080.